Aclaris Therapeutics shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aclaris Therapeutics by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $747k | 393k | 1.90 |
| 2025-06-30 | $630k | 443k | 1.42 |
| 2025-03-31 | $442k | 289k | 1.53 |
| 2024-12-31 | $697k | 281k | 2.48 |
| 2024-09-30 | $229k | 199k | 1.15 |
| 2024-06-30 | $166k | 151k | 1.10 |
| 2021-06-30 | $2.4M | 135k | 17.56 |
| 2021-03-31 | $5.4M | 214k | 25.20 |
| 2020-12-31 | $1.5M | 239k | 6.47 |
| 2020-09-30 | $705k | 274k | 2.57 |
| 2020-06-30 | $445k | 274k | 1.62 |
| 2019-12-31 | $165k | 88k | 1.89 |
| 2019-09-30 | $95k | 88k | 1.09 |
| 2019-06-30 | $192k | 88k | 2.19 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management